News
NEWS: "Hot Off the Press"
- Dr. Fan Zhou – Chairman of the Board, Doctorate Degree
- Dr. William Chai – Director, Doctorate Degree
- Mr. Marc Kealey – Vice Chairman of the Board, Director
- Dr, Jun Huang – Board Director Doctor’s Degree
- Mr. Simon Tang – Director, Doctorate Degree
- Mr. Charles Y. Fu – Senior Vice President, Director
- Mr, Luc Laine – Pegasus NEVs Chairman.
- 1. When was the Company incorporated?
- 2. When did the Company become a public company?
- 3.When is the Company’s fiscal year end?
- Tekumo Announces the Launch of TekumoPRO Version 2.0
- Matthew Perry: A Hollywood Tragedy is a new documentary on how the Friends star died in 2023
- Cycurion (Nasdaq: CYCU) Partners with CentralSquare Technologies to Provide Public Safety IT Services Across the Country
- VSee Issues Shareholder Letter Highlighting 2024 Achievements and Strong Growth Outlook for 2025
- VSee Health Secures $444K County Government Contract, Expanding Market Reach in Public Sector Healthcare
- Cycurion (Nasdaq: CYCU) Awarded Three Multi-Year Contracts Highlighting Growth and Innovation
- Genprex to Participate at BIO Europe Spring 2025
- Safety Shot Announces First Peer-Reviewed Publication of Human Clinical Trial Confirming Rapid Alcohol Reduction and Hangover Prevention
- Cycurion Announces U.S. Launch of its AI Driven SaaS ARx Platform Targeted to the Corporate Sector
- Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
- Reticulate Micro Announces VAST Partner Program
- Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
- Safety Shot, Inc. Appoints CORE IR & PR for Investor Relations, Shareholder Communications and Public Relations Services
- How DeepSeek AI Can Accelerate 1606 Corp’s Chatbot Growth
- Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
- Renovaro Announces $15 million in Equity Committed
- VSee Health and LanguageLine Team Up to Boost Telehealth Adoption with Seamless, Scalable Multilingual Care
- ONAR's AI Marketing Revolution Takes Center Stage at the 8th Annual Centurion One Capital Growth Conference
- Cytta Corp. Reports Over 5000% Increase in Revenue and Sales Receivables as New Registrations for CyttaCOMMS and Drone Force Explode Nationwide
- AI-Driven Future of Retail: How Intelligent Technology is Transforming the Industry
- Safety Shot CEO Jarrett Boon and Yerbaé CEO Todd Gibson Join FORCE Family Webinar to Discuss How Safety Shot Plans to Disrupt the Functional Wellness and Beverage Market
- Cycurion (NASDAQ: CYCU) Expands Cybersecurity Partnership with Leading National Public Health Association
- Reticulate Micro Breakthrough: Real-Time Video Streaming Over HF Radio
- VSee Health Secures $560K Contract to Deploy Virtual Command Center for Major Oncology Network, Strengthening Growth Trajectory in Digital Health Market
- $GPOX Investor Presentation: AI-Powered Distribution Future Revealed-Watch Before Investing!
- Cycurion (NASDAQ: CYCU) and iQSTEL Form Exclusive Cybersecurity Partnership to Expand into High-Tech, High-Margin Markets
- ONAR Announces Signing of Letter of Intent for Strategic Acquisition
- Genprex Advances Diabetes Program with Addition of Research Focused on Non-Viral Delivery System
- Alpha Modus Holdings Inc. (NASDAQ: AMOD) Rings NASDAQ Closing Bell as It Continues Transformative Growth in AI-Driven Investments
- Reticulate Micro Enters into Cooperative Research and Development Agreement with U.S. Special Operations Command
- Genprex Provides Update on Diabetes Gene Therapy Program
- REPEAT -- Cycurion Lists on NASDAQ (CYCU) and Provides Corporate Update
- 1606 Corporation (CBDW) and the Impact of RedChip’s RedChat: A Strong Validation of Our Own AI-Driven IRChat
- Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor
- Metalpha Technology Holding Limited's (NASDAQ:MATH) biggest owners are retail investors who got richer after stock soared 69% last week
- Alpha Modus (Nasdaq: AMOD) Announces AI-Powered Retail Expansion with CashX-Targeting $75 Million in Annual Ad Revenue
- Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex® Delivery System is a Potential Treatment for Anti-PD1 Resistant Non-Small Cell Lung Cancer
- Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex® Delivery System is a Potential Treatment for Anti-PD1 Resistant Non-Small Cell Lung Cancer
- VSee Health Announces Contract with Top Kidney Care Provider to Add VSee Workflow to Oracle Cerner EHR
- NIP Group Forms Strategic Partnership with Optics Valley Traffic Company to Launch Digital Entertainment Hub in Wuhan